Sign in

CIK 0001672619 · Non-accelerated filer

Enliven Therapeutics, Inc.

Sign in to watch
Ticker
ELVN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811523849
Phone
650-547-5814
Business address
205 PARK ROAD, BURLINGAME, CA, 94010
Former names
IMARA Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,230,845
in 7 filings, $1.6M under 10b5-1 plans

Net −$2,230,845. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hohl Benjamin −$887K CHIEF FINANCIAL OFFICER sold 32% of stake
  2. Collins Helen Louise −$737K CHIEF MEDICAL OFFICER sold 38% of stake
  3. Garland J. Scott −$607K Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2020-12-17 Ballal Rahul D. Chief Executive Officer Sale −4,999 $25.00 $125K 0
2020-12-17 Ballal Rahul D. Chief Executive Officer Option exercise · Stock Option (Right to Buy) −4,999 263,999
2020-12-14 Ballal Rahul D. Chief Executive Officer Option exercise +1 $3.15 $3 1
2020-12-14 Ballal Rahul D. Chief Executive Officer Sale −1 $25.00 $25 0
2020-12-14 Ballal Rahul D. Chief Executive Officer Option exercise · Stock Option (Right to Buy) −1 268,998
2020-12-11 GRAY MICHAEL CFO & COO Option exercise +1,250 $4.92 $6K 1,250
2020-12-11 GRAY MICHAEL CFO & COO Sale −1,250 $25.00 $31K 0
2020-12-11 GRAY MICHAEL CFO & COO Option exercise · Stock Option (Right to Buy) −1,250 223,059
2020-04-22 Conner Edward R. Director Grant or award · Stock Option (right to buy) +15,457 15,457
2020-03-16 RA CAPITAL MANAGEMENT, L.P. 10% owner Conversion +829,348 829,348
2020-03-16 RA CAPITAL MANAGEMENT, L.P. 10% owner Purchase +625,000 $16.00 $10.0M 1,454,348
2020-03-16 RA CAPITAL MANAGEMENT, L.P. 10% owner Conversion · Series B Preferred Stock −1,741,358 0
2020-03-16 MOTT DAVID M Director Grant or award · Stock Option (right to buy) +15,457 15,457
2020-03-16 Nayeem Sara M. Director Grant or award · Stock Option (right to buy) +15,457 15,457
2020-03-16 New Enterprise Associates 14, L.P. 10% owner Conversion +3,538,995 3,538,995
2020-03-16 New Enterprise Associates 14, L.P. 10% owner Purchase +475,000 $16.00 $7.6M 4,013,995
2020-03-16 New Enterprise Associates 14, L.P. 10% owner Conversion · Series Seed Preferred Stock −1,342,780 0
2020-03-16 New Enterprise Associates 14, L.P. 10% owner Conversion · Series A Preferred Stock −15,323,454 0
2020-03-16 New Enterprise Associates 14, L.P. 10% owner Conversion · Series B Preferred Stock −5,625,926 0
2020-03-16 Dalton Barbara Director Conversion +1,245,222 1,245,222

Page 38 of 42 · 825 trades